178.72MMarket Cap11.58P/E (TTM)
3.730High3.530Low97.72KVolume3.700Open3.660Pre Close355.87KTurnover0.31%Turnover Ratio8.23P/E (Static)48.24MShares7.73052wk High3.51P/B117.90MFloat Cap2.13052wk Low--Dividend TTM31.82MShs Float279.370Historical High--Div YieldTTM5.46%Amplitude1.600Historical Low3.641Avg Price1Lot Size
Puma Biotechnology Stock Forum
Ready Karen? You gotta learn to ride with the fear 🐆
$Puma Biotechnology(PBYI.US)$
$Puma Biotechnology(PBYI.US)$
it's definitely a diamond studded cougar
$Puma Biotechnology(PBYI.US)$
$Puma Biotechnology(PBYI.US)$
see that yellow line? that's where we are going first. what a ride, huh😉
its no puma, it's a diamond studded cougar!
(it's an old jewelry ad 😆)
$Puma Biotechnology(PBYI.US)$
Well, that went swell 😁 that's my post from the 10th. It received 23k views with 1 cry face and 1 sell comment (2 broke readers💔).
You can read it if you haven't. Here is how I did.
early in the day
And here is how we closed
$iShares Russell 2000 ETF(IWM.US)$ $iShares Russell 2000 ETF(IWM.US)$
Pow Pow 💥
$Trump Media & Technology(DJT.US)$
$GameStop(GME.US)$
this is going to go, it's called buil...
$Trump Media & Technology(DJT.US)$
the memest of memes 🤣
$GameStop(GME.US)$
just getting started (again 😁)
$AMC Entertainment(AMC.US)$
getting toppy, can we blow through this?
$Tilray Brands(TLRY.US)$
I'm high on cannabis
$Coursera(COUR.US)$
could drop to 6.80, but that's a buy for me.
$Puma Biotechnology(PBYI.US)$
oh boy, oh boy, oh boy 😀
$Viking Therapeutics(VKTX.US)$
yeah, it's in the Russell 😃 and I like it a lot
be Safe, Be Careful, Be W...
I also own $Invesco QQQ Trust(QQQ.US)$ and $iShares Russell 2000 ETF(IWM.US)$ calls. if you want to know they are 525 and 220 expiring in September, I've had them a long time, I don't even look at them anymore, I'm up around 1500% on them. I say this because I expect more upside.
I put a lot of faith in 2 stocks today
$Puma Biotechnology(PBYI.US)$
they buy cancer drugs, they try for one's t...
Holy crap Ola that looks sweet 😋 $Puma Biotechnology(PBYI.US)$
$Puma Biotechnology(PBYI.US)$
Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer
Puma Biotechnology (NASDAQ: PBYI) presented findings from a Phase I/Ib study of alisertib in advanced osimertinib-resistant EGFR-mutated non-small cell lung cancer (NSCLC) at the ASCO Annual Meeting. The study, involving 21 patients, found that intermittent dosing of alisertib (30 mg BID) with osimertinib (80 mg daily) was well-tolerate...
📊⚡️📊
No comment yet